title: Medical therapy of adrenocortical tumors.
abstract: Medical therapy is but one of a multiarm, multispecialty approach that is needed in order to successfully treat adrenocortical tumors. The role of surgery, radiation therapy, radiofrequency ablation, and the need for a team approach for the care of the patient cannot be over-emphasized. In this article current and potential future medical therapies for adrenocortical tumors are reviewed.
authors.affiliation: Pediatric Endocrinology, Swedish Pediatric Specialty Clinics, Seattle, WA 98104, USA.
authors.forename: G B
authors.initials: GB
authors.lastname: Kletter
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000188:drug therapy*; D018268:Adrenocortical Carcinoma / Q000150:complications / Q000188:drug therapy*; D000726:Androgen Antagonists / Q000008:administration & dosage; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D018492:Dopamine Antagonists / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000209:etiology; D000451:Mineralocorticoid Receptor Antagonists / Q000008:administration & dosage; D015282:Octreotide / Q000008:administration & dosage; D010348:Patient Care Team; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D018492:Dopamine Antagonists; D005938:Glucocorticoids; D000451:Mineralocorticoid Receptor Antagonists; D015282:Octreotide